<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AB2DDF82-9C96-4248-A6A1-DDCA3F607A18"><gtr:id>AB2DDF82-9C96-4248-A6A1-DDCA3F607A18</gtr:id><gtr:name>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DE956CB8-1DF4-49EB-BC34-78BD6095649A"><gtr:id>DE956CB8-1DF4-49EB-BC34-78BD6095649A</gtr:id><gtr:name>University of KwaZulu-Natal</gtr:name><gtr:address><gtr:line1>Govan Mbeki Centre</gtr:line1><gtr:line2>Westville Campus</gtr:line2><gtr:line3>Private Bag X54001</gtr:line3><gtr:postCode>4000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0B739936-E847-4D0C-8C2A-AE0C504D9F9A"><gtr:id>0B739936-E847-4D0C-8C2A-AE0C504D9F9A</gtr:id><gtr:name>Lausanne University</gtr:name><gtr:address><gtr:line1>Lausanne University</gtr:line1><gtr:line2>Dorigny</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E1CF85FE-1FE2-4BA1-9502-F38CA2D8307A"><gtr:id>E1CF85FE-1FE2-4BA1-9502-F38CA2D8307A</gtr:id><gtr:name>International Diabetes Institute</gtr:name><gtr:address><gtr:line1>250 Kooyong Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1CC23DC2-3991-4123-B5F2-83C1F5793403"><gtr:id>1CC23DC2-3991-4123-B5F2-83C1F5793403</gtr:id><gtr:name>F. Hoffmann-La Roche AG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/931F0B0D-E479-4E31-AF94-5CCAFB6A4445"><gtr:id>931F0B0D-E479-4E31-AF94-5CCAFB6A4445</gtr:id><gtr:name>deCODE Genetics</gtr:name><gtr:address><gtr:line1>Sturlugata 8</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C60CE47-6ED7-4C38-BF0D-BEE689253646"><gtr:id>9C60CE47-6ED7-4C38-BF0D-BEE689253646</gtr:id><gtr:name>Servier Laboratories</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/943DB0F1-D384-486A-85CA-B2C2617F78AA"><gtr:id>943DB0F1-D384-486A-85CA-B2C2617F78AA</gtr:id><gtr:name>Center for Human Genetic Research; Broad Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5F600791-9929-4BAE-9186-DB9F207BD7C1"><gtr:id>5F600791-9929-4BAE-9186-DB9F207BD7C1</gtr:id><gtr:name>McGill University</gtr:name><gtr:address><gtr:line1>845 Sherbrooke Street W</gtr:line1><gtr:line4>Montreal</gtr:line4><gtr:line5>Quebec, H3A 2T5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2795AB81-FD33-413D-BBE4-127D1ACE6210"><gtr:id>2795AB81-FD33-413D-BBE4-127D1ACE6210</gtr:id><gtr:name>University of Chicago</gtr:name><gtr:address><gtr:line1>University of Chicago</gtr:line1><gtr:line2>5801 S Ellis Avenue</gtr:line2><gtr:line4>Chicago</gtr:line4><gtr:line5>IL 60637</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/620DB27D-4014-4278-AAD1-11105CC6BDEA"><gtr:id>620DB27D-4014-4278-AAD1-11105CC6BDEA</gtr:id><gtr:name>Novo Nordisk</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>RDM OCDEM</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB2DDF82-9C96-4248-A6A1-DDCA3F607A18"><gtr:id>AB2DDF82-9C96-4248-A6A1-DDCA3F607A18</gtr:id><gtr:name>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DE956CB8-1DF4-49EB-BC34-78BD6095649A"><gtr:id>DE956CB8-1DF4-49EB-BC34-78BD6095649A</gtr:id><gtr:name>University of KwaZulu-Natal</gtr:name><gtr:address><gtr:line1>Govan Mbeki Centre</gtr:line1><gtr:line2>Westville Campus</gtr:line2><gtr:line3>Private Bag X54001</gtr:line3><gtr:postCode>4000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0B739936-E847-4D0C-8C2A-AE0C504D9F9A"><gtr:id>0B739936-E847-4D0C-8C2A-AE0C504D9F9A</gtr:id><gtr:name>Lausanne University</gtr:name><gtr:address><gtr:line1>Lausanne University</gtr:line1><gtr:line2>Dorigny</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1CF85FE-1FE2-4BA1-9502-F38CA2D8307A"><gtr:id>E1CF85FE-1FE2-4BA1-9502-F38CA2D8307A</gtr:id><gtr:name>International Diabetes Institute</gtr:name><gtr:address><gtr:line1>250 Kooyong Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1CC23DC2-3991-4123-B5F2-83C1F5793403"><gtr:id>1CC23DC2-3991-4123-B5F2-83C1F5793403</gtr:id><gtr:name>F. Hoffmann-La Roche AG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/931F0B0D-E479-4E31-AF94-5CCAFB6A4445"><gtr:id>931F0B0D-E479-4E31-AF94-5CCAFB6A4445</gtr:id><gtr:name>deCODE Genetics</gtr:name><gtr:address><gtr:line1>Sturlugata 8</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C60CE47-6ED7-4C38-BF0D-BEE689253646"><gtr:id>9C60CE47-6ED7-4C38-BF0D-BEE689253646</gtr:id><gtr:name>Servier Laboratories</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/943DB0F1-D384-486A-85CA-B2C2617F78AA"><gtr:id>943DB0F1-D384-486A-85CA-B2C2617F78AA</gtr:id><gtr:name>Center for Human Genetic Research; Broad Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5F600791-9929-4BAE-9186-DB9F207BD7C1"><gtr:id>5F600791-9929-4BAE-9186-DB9F207BD7C1</gtr:id><gtr:name>McGill University</gtr:name><gtr:address><gtr:line1>845 Sherbrooke Street W</gtr:line1><gtr:line4>Montreal</gtr:line4><gtr:line5>Quebec, H3A 2T5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2795AB81-FD33-413D-BBE4-127D1ACE6210"><gtr:id>2795AB81-FD33-413D-BBE4-127D1ACE6210</gtr:id><gtr:name>University of Chicago</gtr:name><gtr:address><gtr:line1>University of Chicago</gtr:line1><gtr:line2>5801 S Ellis Avenue</gtr:line2><gtr:line4>Chicago</gtr:line4><gtr:line5>IL 60637</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/620DB27D-4014-4278-AAD1-11105CC6BDEA"><gtr:id>620DB27D-4014-4278-AAD1-11105CC6BDEA</gtr:id><gtr:name>Novo Nordisk</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/306DBCE5-68E6-4D3E-8912-78D0AC0653C0"><gtr:id>306DBCE5-68E6-4D3E-8912-78D0AC0653C0</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Morris</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EB134AF9-197A-4970-8C8E-6D9132EBEB02"><gtr:id>EB134AF9-197A-4970-8C8E-6D9132EBEB02</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Ian</gtr:otherNames><gtr:surname>McCarthy</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D5ED1902-A9CA-4CEC-AFE9-5ED40B765776"><gtr:id>D5ED1902-A9CA-4CEC-AFE9-5ED40B765776</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Palmer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E2876A69-51A3-45F3-988E-9B2F2F453C2B"><gtr:id>E2876A69-51A3-45F3-988E-9B2F2F453C2B</gtr:id><gtr:firstName>Lon</gtr:firstName><gtr:surname>Cardon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/63454C57-257F-4FAE-8D1D-410381F0B810"><gtr:id>63454C57-257F-4FAE-8D1D-410381F0B810</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Hattersley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D2B64DCB-0D07-422F-B36B-C29656BF5A55"><gtr:id>D2B64DCB-0D07-422F-B36B-C29656BF5A55</gtr:id><gtr:firstName>Timothy</gtr:firstName><gtr:otherNames>Mark</gtr:otherNames><gtr:surname>Frayling</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601261"><gtr:id>D322212B-1D71-4306-8E2A-17CCF62870B1</gtr:id><gtr:title>Translating genome-wide association data from the WTCCC study into biological and clinical insights in type 2 diabetes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601261</gtr:grantReference><gtr:abstractText>Diabetes is a major and growing cause of disease and death in the UK and beyond. Most diabetes arising after early adulthood is due to ?type 2 diabetes?: almost 10 percent of the world?s population either has this condition or will develop it during their lifetime. Despite this global importance, understanding of the processes which lead to development of type 2 diabetes is far from complete, and much needs to be done to develop more effective approaches to prevention and treatment. 

One of the most promising routes to a better understanding of diabetes comes from identifying the genes which influence an individual?s predisposition to develop the disease. In recent years, there have been some promising developments and several such genes have been identified. More recently, through advances in knowledge and technology that have followed the sequencing of the human genome, it has become possible to search for such genes in a systematic and ?genomewide? fashion. The applicants on this proposal are currently completing such a ?genomewide association? study (the largest yet conducted into the genetics of diabetes). Analysis of the experimental data will commence shortly and will provide initial clues to the locations of many novel diabetes genes. However, a great deal of work will still be required to separate real effects from spurious findings due to chance or error, and to establish beyond doubt the identities of the genes involved. This work, which involves studying a further 50,000 DNA samples, occupies the first part of our research proposal.

With such a set of confirmed diabetes-susceptibility signals in hand, we aim to translate these discoveries into an improved understanding of the biology of diabetes. We will do this in various ways: for instance, by studying how these genes interact with environmental factors (poor diet, lack of exercise) to influence risk of diabetes. Finally, we want to see whether it is practical to use this genetic information to improve the treatment and prevention of diabetes. We will ask whether the genetic differences we have identified will allow us to predict how likely it is that a given individual will develop diabetes and which treatments may be particularly beneficial. 

The work will be performed by groups in Oxford, Exeter and Dundee who have spent the last decade working together to understand the causes of type 2 diabetes. The funding requested will enable them to make major strides towards this goal.</gtr:abstractText><gtr:technicalSummary>Recent advances in the understanding of human genome sequence variation, allied to advances in genotyping technology and availability of large well-characterized clinical samples have reinvigorated efforts to identify the variants influencing susceptibility to type 2 diabetes (T2D). The Wellcome Trust Case Control Consortium is the largest genome-wide association study currently in progress worldwide and genotyping of 2000 T2D cases and 3000 UK controls on the 500k Affymetrix platform will be complete by October 2006. The current proposal outlines our plans to follow-up the findings of this unprecedented study of T2D genetics using the extensive clinical resources available to the applicants and their collaborators. We plan to:

(a) perform extensive validation and replication studies to ensure robust identification of the principal common T2D-susceptibility SNPs against the background of type 1 error and undetected bias. Key to this exercise are plans for combined analysis of all available dense-map T2D genome-wide association data (~5500 cases, 6500 controls from 4 groups) in early 2007 through the IGWANA consortium. We will take the 1500 variants with the most compelling association signals from this combined analysis through successive rounds of validation and replication involving up to 50,000 samples. As we show, this design provides excellent power to retrieve the majority of common SNP-based variants with modest or large T2D-susceptibility effects with negligibly low false positive report probabilities; 

(b) identify the variants driving each association signal (through fine-mapping, resequencing, and assays of copy number variation);

(c) translate these findings into insights into the epidemiology, physiology, genetic architecture and biology of T2D, in studies of over 100,000 samples available to the applicants and their collaborators;

(d) evaluate the potential for the application of the findings to the clinical management of diabetes. A key resource will be the Wellcome-Trust-funded Dundee-based UK Type 2 Diabetes Genetics Consortium Case-Control Collection which provides substantial health-related outcome data on over 7000 diabetic cases within the UK?s most-advanced record linkage system.

The applicants have a strong track-record in the successful implementation of large-scale genetic studies. They have pioneered large-scale association studies in T2D, have responsibility for the T2D component of the WTCCC and are playing a leading role in several major international genetics consortia. They are uniquely-placed to deliver insights into the pathogenesis of T2D, and to initiate the task of translating those findings into advances in clinical care.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1475758</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Los Angeles (UCLA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine UCLA</gtr:department><gtr:description>CHARGE, T2DGENES, PROMIS exome array</gtr:description><gtr:id>2A208D1B-3F32-403D-9B4C-C850D79001C7</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>545e9b6ab1d4b2.56118990-1</gtr:outcomeId><gtr:partnerContribution>Other groups are bringing data from CHARGE and PROMIS</gtr:partnerContribution><gtr:piContribution>WE are collaborating to bring together exome chip data on ~250000 individuals with/without T2D. We bring data from DIAGRAM/T2DGENES</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Los Angeles (UCLA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>PAGE consortium</gtr:description><gtr:id>FBE19702-257E-4C0C-B1BB-F9486F9FA0ED</gtr:id><gtr:impact>Design of an array</gtr:impact><gtr:outcomeId>bCaEPCNX8DM-1</gtr:outcomeId><gtr:partnerContribution>With T2DGENES colleagues we designed the array</gtr:partnerContribution><gtr:piContribution>Collaboration to design and genotype a transethnic genotyping array</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>SUMMIT</gtr:description><gtr:id>CF21C317-1139-4384-A784-82E27D38EEE7</gtr:id><gtr:impact>Tangible ouput is 30M euros of funding from EU and pharma
Publications 2013</gtr:impact><gtr:outcomeId>EB096D4A910-6</gtr:outcomeId><gtr:partnerContribution>This project is funded by EU-IMI. WE lead WP1, have analysed most of teh GWAS data and performed and analysed exome sequencing data. Publications anticipated 2013.</gtr:partnerContribution><gtr:piContribution>I am one of the leaders of the consortium with responsiblity specifically for the GWA studies of diabetes complciations at the core of the proposal. It has been funded to a total of ?28M by the EU and EFPIA partners under the IMI initiative</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Michigan Medical School</gtr:department><gtr:description>T2D-GENES</gtr:description><gtr:id>325F9196-5DE0-41AD-AD3A-7A3B65A68FA8</gtr:id><gtr:impact>Data generation currently, based around next-generation sequencing. We expect high profile publications in 2013.</gtr:impact><gtr:outcomeId>XgWtTGUvfX6-3</gtr:outcomeId><gtr:partnerContribution>Overall program is funded to a total of $24M so far and designed to encourage transethnic studies in t2D genetics. Oxford is on the steering committee of the project, and also heads one of the five funded consortia within the effort. We play a major role in planning, sample provision, analysis and informatics.</gtr:partnerContribution><gtr:piContribution>Oxford is on the steering committee of the project, and also heads one of the five funded consortia within the effort. We play a major role in planning, sample provision, analysis and informatics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Center for Human Genetic Research; Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GTEX</gtr:description><gtr:id>574AA31C-F544-4A41-959C-291AD3673C25</gtr:id><gtr:impact>Several papers emerging including 24037378</gtr:impact><gtr:outcomeId>BCpz1JPckAs-1</gtr:outcomeId><gtr:partnerContribution>We have contributed analyses relating expresison data to GWAS signals</gtr:partnerContribution><gtr:piContribution>I lead one component of the analytical research related ot the GTEX project, as part of a recurrent R01 award held by PI Dermitzakis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DIRECT</gtr:description><gtr:id>259D6A85-E565-411F-85B5-1E1E6569B370</gtr:id><gtr:impact>Success in obtaining approx 45M? total funding (from the IMI and from pharma) for the DIRECT program of research from 2012 - 2018</gtr:impact><gtr:outcomeId>cPYVGFCzFm5-5</gtr:outcomeId><gtr:partnerContribution>Integrates our genetic and genomic appproaches with clinical resources to identify biomarkers able to support stratified medicine for T2D</gtr:partnerContribution><gtr:piContribution>This EU IMI grant is worth about ?45M. I was part of the writing committee for the final proposal and will lead on one of the major workpackages. The grant officially kicks off in 2012 but the collaboration started in 2010</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novo Nordisk</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>DIRECT</gtr:description><gtr:id>A20035BD-273C-46E1-B912-1C2E3AF1262D</gtr:id><gtr:impact>Success in obtaining approx 45M? total funding (from the IMI and from pharma) for the DIRECT program of research from 2012 - 2018</gtr:impact><gtr:outcomeId>cPYVGFCzFm5-4</gtr:outcomeId><gtr:partnerContribution>Integrates our genetic and genomic appproaches with clinical resources to identify biomarkers able to support stratified medicine for T2D</gtr:partnerContribution><gtr:piContribution>This EU IMI grant is worth about ?45M. I was part of the writing committee for the final proposal and will lead on one of the major workpackages. The grant officially kicks off in 2012 but the collaboration started in 2010</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Strangeways Research Laboratory</gtr:department><gtr:description>EpiMIGRANT</gtr:description><gtr:id>37305641-F336-4811-B2FC-06F2B1A1CDC5</gtr:id><gtr:impact>The project starts in 2012.</gtr:impact><gtr:outcomeId>gXjEx7a9Ca7-3</gtr:outcomeId><gtr:partnerContribution>Will enable large-scale epigenetic analysis of South Asians with and without T2D.Epigenomics of T2D in South AsiansEpugenomics of T2D in south Asians</gtr:partnerContribution><gtr:piContribution>I am part of the leadership team for the EU award and wil lead one of the WPs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Aventis</gtr:department><gtr:description>STEMBANCC</gtr:description><gtr:id>DF23FC47-2530-4B4F-9DD6-38B8B73EF8A9</gtr:id><gtr:impact>Nil to date</gtr:impact><gtr:outcomeId>n2hkkB1ttjr-3</gtr:outcomeId><gtr:partnerContribution>We will provide clinical material (from patients), characterise stem cell derived tissues derived and manage the diabetes work package</gtr:partnerContribution><gtr:piContribution>This is a new IMI collaboration (total funding 53M? from IMI and in kind) to Oxford and 25 other academic institutions.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>STEMBANCC</gtr:description><gtr:id>D88B7D51-39DF-4672-8F2E-B182E7FB44F1</gtr:id><gtr:impact>Nil to date</gtr:impact><gtr:outcomeId>n2hkkB1ttjr-4</gtr:outcomeId><gtr:partnerContribution>We will provide clinical material (from patients), characterise stem cell derived tissues derived and manage the diabetes work package</gtr:partnerContribution><gtr:piContribution>This is a new IMI collaboration (total funding 53M? from IMI and in kind) to Oxford and 25 other academic institutions.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EGG (Early Growth Genetics) consortium</gtr:description><gtr:id>C0AC8BB8-F9C8-444F-BBFA-FA8E6607BED5</gtr:id><gtr:impact>This is a large international colaboration that has enabled large-scale association studies in early growth genetics resulting in several publications and ongoing high profile research activity. We published on BW in Nature Genetics in 2010, and there are ~10 further high profile publications under review or in preparation from the wider consortium relating the genetic basis of many early growth phenotypes.</gtr:impact><gtr:outcomeId>CE061F3B38D-1</gtr:outcomeId><gtr:partnerContribution>This is a large international colaboration that has enabled large-scale association studies in early growth genetics resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>We lead this effort which has so far netted the first common variants influencing birth weight and promises to result in insights into other early growth phenotypes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>SUMMIT</gtr:description><gtr:id>72423BB0-1929-4204-B0A5-1765F786052D</gtr:id><gtr:impact>Tangible ouput is 30M euros of funding from EU and pharma
Publications 2013</gtr:impact><gtr:outcomeId>EB096D4A910-1</gtr:outcomeId><gtr:partnerContribution>This project is funded by EU-IMI. WE lead WP1, have analysed most of teh GWAS data and performed and analysed exome sequencing data. Publications anticipated 2013.</gtr:partnerContribution><gtr:piContribution>I am one of the leaders of the consortium with responsiblity specifically for the GWA studies of diabetes complciations at the core of the proposal. It has been funded to a total of ?28M by the EU and EFPIA partners under the IMI initiative</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>T2D-GENES</gtr:description><gtr:id>2390593A-DD42-45C0-8B9A-4029494B3BDD</gtr:id><gtr:impact>Data generation currently, based around next-generation sequencing. We expect high profile publications in 2013.</gtr:impact><gtr:outcomeId>XgWtTGUvfX6-1</gtr:outcomeId><gtr:partnerContribution>Overall program is funded to a total of $24M so far and designed to encourage transethnic studies in t2D genetics. Oxford is on the steering committee of the project, and also heads one of the five funded consortia within the effort. We play a major role in planning, sample provision, analysis and informatics.</gtr:partnerContribution><gtr:piContribution>Oxford is on the steering committee of the project, and also heads one of the five funded consortia within the effort. We play a major role in planning, sample provision, analysis and informatics.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The MUTHER (Multiple Tissues for Human Expression Resource) Consortium</gtr:description><gtr:id>9EFA093D-36C9-4F8A-9226-BB3B603171A9</gtr:id><gtr:impact>We have assembled one of the largest tissue expression banks available and are instituting detailed analysis. Two papers have already been published in high profile journals (Nica, PLoS GENETICS 2010; Small Nature genetics 2011) and further publications are in preparation as of Oct 2011.</gtr:impact><gtr:outcomeId>A6517F75523-1</gtr:outcomeId><gtr:partnerContribution>it has supported methods development, and provided samples and a collaborative network for analysis of expression and methylation data relevant to multiple human traits. it has supported methods development, and provided samples and a collaborative network for analysis of expression and methylation data relevant to multiple human traits. it has supported methods development, and provided samples and a collaborative network for analysis of expression and methylation data relevant to multiple human traits.</gtr:partnerContribution><gtr:piContribution>We have contributed to sample preparation, database design and to data analysis</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McGill University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>DIAGRAM (Diabetes Replication and Meta-analysis) consortium</gtr:description><gtr:id>8F347822-C667-4D1B-BAE0-125BEAB55549</gtr:id><gtr:impact>In published work, we have identified ~12 novel T2D susceptibility genes, and in unpublished work (currently submitted or in press) a further 20 or so. This consortium leads international efforts to understand T2D genetics 18372903 19060907 Dupuis et al, NG, in press Other outputs (not directly attributed to MRC funding) 19252133 19526209 18591388 18853133 19056611 19933169. The consortium is now (Oct 2011) preparing publications related to our activities with the metabochip, and on imputation from 1000Genomes into large GWA datasets.</gtr:impact><gtr:outcomeId>A5FC66319DA-5</gtr:outcomeId><gtr:partnerContribution>This is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>My group leads this international effort.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>METABOCHIP consortium</gtr:description><gtr:id>D31E0B51-B57F-4749-8940-C754EA356DB9</gtr:id><gtr:impact>This is a large international colaboration that has designed a chip to enable largescale replication and fine mapping of several cardiovascular and metabolic traits. The typing and analysis of these data are ongoing.</gtr:impact><gtr:outcomeId>6DF745D297B-2</gtr:outcomeId><gtr:partnerContribution>This is a large international colaboration that has designed a chip to enable largescale replication and fine mapping of several cardiovascular and metabolic traits. The typing and analysis of these data are ongoing.</gtr:partnerContribution><gtr:piContribution>We co-lead this effort.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MAGIC (Meta-analysis of Glycaemic and Insulin related traits) Consortium</gtr:description><gtr:id>EF2287A2-B17E-4CFE-9AB0-08ECEDBF4CE5</gtr:id><gtr:impact>This group has identified ~20 genome wide significant signals influencing continuous glycemic traits, a subset of which also influence T2D risk. This has resulted in a number of high profile publications (qv). 19060907 Dupuis et al, NG, 2010. Further publications have arisen over the past few years, and a new batch of publications is currently (Oct 2011) being prepared related to metabochip data.</gtr:impact><gtr:outcomeId>044D314F8F8-1</gtr:outcomeId><gtr:partnerContribution>This is a large international colaboration that has enabled large-scale association studies in continuous glycemic traits resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>We co-lead this collaboration of over 70 groups worldwide (it is impractical for me to enter the details in this form) working on the genetic basis of glycemic traits.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>DIAGRAM (Diabetes Replication and Meta-analysis) consortium</gtr:description><gtr:id>0A5CED32-C841-42CE-9BDF-722C7208B95A</gtr:id><gtr:impact>In published work, we have identified ~12 novel T2D susceptibility genes, and in unpublished work (currently submitted or in press) a further 20 or so. This consortium leads international efforts to understand T2D genetics 18372903 19060907 Dupuis et al, NG, in press Other outputs (not directly attributed to MRC funding) 19252133 19526209 18591388 18853133 19056611 19933169. The consortium is now (Oct 2011) preparing publications related to our activities with the metabochip, and on imputation from 1000Genomes into large GWA datasets.</gtr:impact><gtr:outcomeId>A5FC66319DA-6</gtr:outcomeId><gtr:partnerContribution>This is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>My group leads this international effort.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Geneva</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>GTEX</gtr:description><gtr:id>646C48D5-2A8A-400D-87BC-A7EC86A74167</gtr:id><gtr:impact>Several papers emerging including 24037378</gtr:impact><gtr:outcomeId>BCpz1JPckAs-2</gtr:outcomeId><gtr:partnerContribution>We have contributed analyses relating expresison data to GWAS signals</gtr:partnerContribution><gtr:piContribution>I lead one component of the analytical research related ot the GTEX project, as part of a recurrent R01 award held by PI Dermitzakis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novo Nordisk</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>STEMBANCC</gtr:description><gtr:id>10478D47-27CF-422C-B91E-2CDFC2745051</gtr:id><gtr:impact>Nil to date</gtr:impact><gtr:outcomeId>n2hkkB1ttjr-2</gtr:outcomeId><gtr:partnerContribution>We will provide clinical material (from patients), characterise stem cell derived tissues derived and manage the diabetes work package</gtr:partnerContribution><gtr:piContribution>This is a new IMI collaboration (total funding 53M? from IMI and in kind) to Oxford and 25 other academic institutions.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>F. Hoffmann-La Roche AG</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>STEMBANCC</gtr:description><gtr:id>A130C67F-3B9B-41CF-A508-41DFF44BE9A8</gtr:id><gtr:impact>Nil to date</gtr:impact><gtr:outcomeId>n2hkkB1ttjr-1</gtr:outcomeId><gtr:partnerContribution>We will provide clinical material (from patients), characterise stem cell derived tissues derived and manage the diabetes work package</gtr:partnerContribution><gtr:piContribution>This is a new IMI collaboration (total funding 53M? from IMI and in kind) to Oxford and 25 other academic institutions.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Exeter</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CEED3</gtr:description><gtr:id>5F89A8A0-FBEB-4E9A-A41D-74DBDFCEBF54</gtr:id><gtr:impact>This supports large-scale data integration relevant to diabetes diagnostics and has led to high profile publications and ongoing high profile research.</gtr:impact><gtr:outcomeId>9C1F3440820-1</gtr:outcomeId><gtr:partnerContribution>This supports large-scale data integration and has led to high profile publications and ongoing high profile research.</gtr:partnerContribution><gtr:piContribution>I am on the steering committee and lead aspects of one work package.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Medical and Population Genetics Program</gtr:department><gtr:description>Genetics of Type 2 diabetes (GoT2D)</gtr:description><gtr:id>ED73F878-C85A-4725-BCD1-ED9CD44F0808</gtr:id><gtr:impact>Multidiscipinary - genetics, genomics, statistics, informatics. Data generation at present. High profile publications expected in due course. We have (Oct 2011) almost completed data generation (~2850 samples with whole genome, whole exome and dense genotype data) and proceeding to analysis</gtr:impact><gtr:outcomeId>BokxJ52CBkw-1</gtr:outcomeId><gtr:partnerContribution>We are jointly responsible for the largest study in type 2 diabetes genetics currently ongoing - including whole genome sequencing of 2650 individuals. see under Broad</gtr:partnerContribution><gtr:piContribution>Oxford is jointly responsible for this high profile project funded to a total of $20M by the NIH, another $10M by NHGRI and &amp;pound;2.5M by the Wellcome Trust. We are undertaking whole genome sequencing of 650 individuals</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DOLORISK</gtr:description><gtr:id>FD3B86A0-5752-4BCA-8B9C-C600EB8F7102</gtr:id><gtr:impact>Still in progress</gtr:impact><gtr:outcomeId>58c56bf468f0d6.53673488-1</gtr:outcomeId><gtr:partnerContribution>Dundee (and other partners not listed) have provided samples for us to GWAS</gtr:partnerContribution><gtr:piContribution>WE are responsible for the genetics WP of this H2020 consortium</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Lausanne</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>RHAPSODY</gtr:description><gtr:id>E89098B1-86B0-44F2-8E00-1DA0DCF4638B</gtr:id><gtr:impact>Still in early stages</gtr:impact><gtr:outcomeId>58c56c8fd69fe7.85073728-1</gtr:outcomeId><gtr:partnerContribution>There are around 20 academic groups and 5 pharma companies involved in this consortium</gtr:partnerContribution><gtr:piContribution>My group coleads WP5 in this IMI consortium</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DIAGRAM (Diabetes Replication and Meta-analysis) consortium</gtr:description><gtr:id>420E950C-246F-49C6-9B29-E81644C11112</gtr:id><gtr:impact>In published work, we have identified ~12 novel T2D susceptibility genes, and in unpublished work (currently submitted or in press) a further 20 or so. This consortium leads international efforts to understand T2D genetics 18372903 19060907 Dupuis et al, NG, in press Other outputs (not directly attributed to MRC funding) 19252133 19526209 18591388 18853133 19056611 19933169. The consortium is now (Oct 2011) preparing publications related to our activities with the metabochip, and on imputation from 1000Genomes into large GWA datasets.</gtr:impact><gtr:outcomeId>A5FC66319DA-3</gtr:outcomeId><gtr:partnerContribution>This is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>My group leads this international effort.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>DIAGRAM (Diabetes Replication and Meta-analysis) consortium</gtr:description><gtr:id>7D8DB8A5-8EFF-4FA0-A0E0-95CD32A3EEA9</gtr:id><gtr:impact>In published work, we have identified ~12 novel T2D susceptibility genes, and in unpublished work (currently submitted or in press) a further 20 or so. This consortium leads international efforts to understand T2D genetics 18372903 19060907 Dupuis et al, NG, in press Other outputs (not directly attributed to MRC funding) 19252133 19526209 18591388 18853133 19056611 19933169. The consortium is now (Oct 2011) preparing publications related to our activities with the metabochip, and on imputation from 1000Genomes into large GWA datasets.</gtr:impact><gtr:outcomeId>A5FC66319DA-1</gtr:outcomeId><gtr:partnerContribution>This is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>My group leads this international effort.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Michigan Medical School</gtr:department><gtr:description>Genetics of Type 2 diabetes (GoT2D)</gtr:description><gtr:id>8451954B-E102-491C-992E-FEC65E4FCFDD</gtr:id><gtr:impact>Multidiscipinary - genetics, genomics, statistics, informatics. Data generation at present. High profile publications expected in due course. We have (Oct 2011) almost completed data generation (~2850 samples with whole genome, whole exome and dense genotype data) and proceeding to analysis</gtr:impact><gtr:outcomeId>BokxJ52CBkw-2</gtr:outcomeId><gtr:partnerContribution>We are jointly responsible for the largest study in type 2 diabetes genetics currently ongoing - including whole genome sequencing of 2650 individuals. see under Broad</gtr:partnerContribution><gtr:piContribution>Oxford is jointly responsible for this high profile project funded to a total of $20M by the NIH, another $10M by NHGRI and &amp;pound;2.5M by the Wellcome Trust. We are undertaking whole genome sequencing of 650 individuals</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Geneva</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>The MUTHER (Multiple Tissues for Human Expression Resource) Consortium</gtr:description><gtr:id>28CC11C6-F22F-4DF6-B44E-82897DB36C88</gtr:id><gtr:impact>We have assembled one of the largest tissue expression banks available and are instituting detailed analysis. Two papers have already been published in high profile journals (Nica, PLoS GENETICS 2010; Small Nature genetics 2011) and further publications are in preparation as of Oct 2011.</gtr:impact><gtr:outcomeId>A6517F75523-3</gtr:outcomeId><gtr:partnerContribution>it has supported methods development, and provided samples and a collaborative network for analysis of expression and methylation data relevant to multiple human traits. it has supported methods development, and provided samples and a collaborative network for analysis of expression and methylation data relevant to multiple human traits. it has supported methods development, and provided samples and a collaborative network for analysis of expression and methylation data relevant to multiple human traits.</gtr:partnerContribution><gtr:piContribution>We have contributed to sample preparation, database design and to data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Public Health</gtr:department><gtr:description>EpiMIGRANT</gtr:description><gtr:id>63123583-3F54-42E9-9A10-3FC75654FF38</gtr:id><gtr:impact>The project starts in 2012.</gtr:impact><gtr:outcomeId>gXjEx7a9Ca7-1</gtr:outcomeId><gtr:partnerContribution>Will enable large-scale epigenetic analysis of South Asians with and without T2D.Epigenomics of T2D in South AsiansEpugenomics of T2D in south Asians</gtr:partnerContribution><gtr:piContribution>I am part of the leadership team for the EU award and wil lead one of the WPs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Mendelian Randomisation to help identify potential adverse effects of drug treatments</gtr:description><gtr:id>E983CD85-CAD2-4B73-AF87-5C4CA9A6CB07</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>58c0180443f686.10120337-1</gtr:outcomeId><gtr:partnerContribution>GSK are providing the expertise in cardio vascular endpoints and contributing financially to staff in Exeter. This collaboration stimulated an MRC CASE studentship award which will begin in September 2017.</gtr:partnerContribution><gtr:piContribution>We are working with GSK to perform genetic tests to understand potential adverse effects of cardio vascular drug treatments. These include those affecting the HIF pathway and anaemia in Chronic kidney disease such as EPO stimulating agents.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boehringer Ingelheim</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>SUMMIT</gtr:description><gtr:id>D1EEF22D-72D2-44AF-ADF3-BBC5E1356CDC</gtr:id><gtr:impact>Tangible ouput is 30M euros of funding from EU and pharma
Publications 2013</gtr:impact><gtr:outcomeId>EB096D4A910-2</gtr:outcomeId><gtr:partnerContribution>This project is funded by EU-IMI. WE lead WP1, have analysed most of teh GWAS data and performed and analysed exome sequencing data. Publications anticipated 2013.</gtr:partnerContribution><gtr:piContribution>I am one of the leaders of the consortium with responsiblity specifically for the GWA studies of diabetes complciations at the core of the proposal. It has been funded to a total of ?28M by the EU and EFPIA partners under the IMI initiative</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Perelman School of Medicine</gtr:department><gtr:description>CHARGE, T2DGENES, PROMIS exome array</gtr:description><gtr:id>3FBD9C44-425F-486A-B4E3-DA5E0BAE0DEC</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>545e9b6ab1d4b2.56118990-2</gtr:outcomeId><gtr:partnerContribution>Other groups are bringing data from CHARGE and PROMIS</gtr:partnerContribution><gtr:piContribution>WE are collaborating to bring together exome chip data on ~250000 individuals with/without T2D. We bring data from DIAGRAM/T2DGENES</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Case Control Consortium (extension)</gtr:description><gtr:id>6BDFE5CF-14BA-42F2-85BE-9D67AA710BE1</gtr:id><gtr:impact>This has led to pioneering work in the field - the first papers are currently under review at Nature and other journals.</gtr:impact><gtr:outcomeId>5EEAB65956E-2</gtr:outcomeId><gtr:partnerContribution>We collaborate to understand the impact of CNVs on common disease predisposition and to fine map causal variants for these diseases.</gtr:partnerContribution><gtr:piContribution>We lead the T2D component of this work as well as contributing to study design and analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>H3Africa</gtr:description><gtr:id>00407722-A072-4850-B090-85A2FBD22E19</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>AaKdzuG1CwJ-1</gtr:outcomeId><gtr:partnerContribution>We have designed and are now implementing a large collection of T2D cases and controls in Africa</gtr:partnerContribution><gtr:piContribution>I am part of the H3A funded project on diabetes in Africa.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Chicago</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>T2D-GENES</gtr:description><gtr:id>D8909935-438A-43F9-B22B-6A201C50D03B</gtr:id><gtr:impact>Data generation currently, based around next-generation sequencing. We expect high profile publications in 2013.</gtr:impact><gtr:outcomeId>XgWtTGUvfX6-4</gtr:outcomeId><gtr:partnerContribution>Overall program is funded to a total of $24M so far and designed to encourage transethnic studies in t2D genetics. Oxford is on the steering committee of the project, and also heads one of the five funded consortia within the effort. We play a major role in planning, sample provision, analysis and informatics.</gtr:partnerContribution><gtr:piContribution>Oxford is on the steering committee of the project, and also heads one of the five funded consortia within the effort. We play a major role in planning, sample provision, analysis and informatics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>SUMMIT</gtr:description><gtr:id>C51A53F4-8AEE-4351-94B4-A370E39CB81A</gtr:id><gtr:impact>Tangible ouput is 30M euros of funding from EU and pharma
Publications 2013</gtr:impact><gtr:outcomeId>EB096D4A910-5</gtr:outcomeId><gtr:partnerContribution>This project is funded by EU-IMI. WE lead WP1, have analysed most of teh GWAS data and performed and analysed exome sequencing data. Publications anticipated 2013.</gtr:partnerContribution><gtr:piContribution>I am one of the leaders of the consortium with responsiblity specifically for the GWA studies of diabetes complciations at the core of the proposal. It has been funded to a total of ?28M by the EU and EFPIA partners under the IMI initiative</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GIANT (Genetic Investigation of Anthropometric Traits) Consortium</gtr:description><gtr:id>E746CD97-0CF0-4361-9794-7DFFE9A7D6FB</gtr:id><gtr:impact>This is a large international colaboration that has enabled large-scale association studies in anthropometric traits resulting in several publications and ongoing high profile research activity 18454148 19079261 OTher outputs (not directly funded by MRC) but arising from the partnership 17767157 18346983 18391952 18842783 19005641 19557161</gtr:impact><gtr:outcomeId>B3B4F9B768A-2</gtr:outcomeId><gtr:partnerContribution>This is a large international colaboration that has enabled large-scale association studies in anthropometric traits resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>We co-lead this effort, contributing data and analysis and expertise to the study of the genetics of height, BMI and central obesity phenotypes.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biomedical Research Institute</gtr:department><gtr:description>DIRECT</gtr:description><gtr:id>71F5E94D-2FEF-4306-9CFA-B3AE7D974A7D</gtr:id><gtr:impact>Success in obtaining approx 45M? total funding (from the IMI and from pharma) for the DIRECT program of research from 2012 - 2018</gtr:impact><gtr:outcomeId>cPYVGFCzFm5-1</gtr:outcomeId><gtr:partnerContribution>Integrates our genetic and genomic appproaches with clinical resources to identify biomarkers able to support stratified medicine for T2D</gtr:partnerContribution><gtr:piContribution>This EU IMI grant is worth about ?45M. I was part of the writing committee for the final proposal and will lead on one of the major workpackages. The grant officially kicks off in 2012 but the collaboration started in 2010</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of KwaZulu-Natal</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>H3Africa</gtr:description><gtr:id>DA849E3A-D31B-4E64-8C0F-66C8EEB3F0A5</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>AaKdzuG1CwJ-3</gtr:outcomeId><gtr:partnerContribution>We have designed and are now implementing a large collection of T2D cases and controls in Africa</gtr:partnerContribution><gtr:piContribution>I am part of the H3A funded project on diabetes in Africa.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>SUMMIT</gtr:description><gtr:id>BF3EE411-CEF0-4E93-9555-4C86DB9B7D75</gtr:id><gtr:impact>Tangible ouput is 30M euros of funding from EU and pharma
Publications 2013</gtr:impact><gtr:outcomeId>EB096D4A910-4</gtr:outcomeId><gtr:partnerContribution>This project is funded by EU-IMI. WE lead WP1, have analysed most of teh GWAS data and performed and analysed exome sequencing data. Publications anticipated 2013.</gtr:partnerContribution><gtr:piContribution>I am one of the leaders of the consortium with responsiblity specifically for the GWA studies of diabetes complciations at the core of the proposal. It has been funded to a total of ?28M by the EU and EFPIA partners under the IMI initiative</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Diabetes Institute (IDI)</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>EpiMIGRANT</gtr:description><gtr:id>ED98A135-1CD6-40A7-8C6E-757199473408</gtr:id><gtr:impact>The project starts in 2012.</gtr:impact><gtr:outcomeId>gXjEx7a9Ca7-2</gtr:outcomeId><gtr:partnerContribution>Will enable large-scale epigenetic analysis of South Asians with and without T2D.Epigenomics of T2D in South AsiansEpugenomics of T2D in south Asians</gtr:partnerContribution><gtr:piContribution>I am part of the leadership team for the EU award and wil lead one of the WPs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The MUTHER (Multiple Tissues for Human Expression Resource) Consortium</gtr:description><gtr:id>4A23D6A1-B373-47E7-ABCD-A4FBEE9088FE</gtr:id><gtr:impact>We have assembled one of the largest tissue expression banks available and are instituting detailed analysis. Two papers have already been published in high profile journals (Nica, PLoS GENETICS 2010; Small Nature genetics 2011) and further publications are in preparation as of Oct 2011.</gtr:impact><gtr:outcomeId>A6517F75523-2</gtr:outcomeId><gtr:partnerContribution>it has supported methods development, and provided samples and a collaborative network for analysis of expression and methylation data relevant to multiple human traits. it has supported methods development, and provided samples and a collaborative network for analysis of expression and methylation data relevant to multiple human traits. it has supported methods development, and provided samples and a collaborative network for analysis of expression and methylation data relevant to multiple human traits.</gtr:partnerContribution><gtr:piContribution>We have contributed to sample preparation, database design and to data analysis</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Medical and Population Genetics Program</gtr:department><gtr:description>T2D-GENES</gtr:description><gtr:id>CE75D62C-2BF9-47BF-AA55-A060E844D027</gtr:id><gtr:impact>Data generation currently, based around next-generation sequencing. We expect high profile publications in 2013.</gtr:impact><gtr:outcomeId>XgWtTGUvfX6-2</gtr:outcomeId><gtr:partnerContribution>Overall program is funded to a total of $24M so far and designed to encourage transethnic studies in t2D genetics. Oxford is on the steering committee of the project, and also heads one of the five funded consortia within the effort. We play a major role in planning, sample provision, analysis and informatics.</gtr:partnerContribution><gtr:piContribution>Oxford is on the steering committee of the project, and also heads one of the five funded consortia within the effort. We play a major role in planning, sample provision, analysis and informatics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>DIAGRAM (Diabetes Replication and Meta-analysis) consortium</gtr:description><gtr:id>5C9CC342-86C8-4CA1-B4C4-6B4416615B89</gtr:id><gtr:impact>In published work, we have identified ~12 novel T2D susceptibility genes, and in unpublished work (currently submitted or in press) a further 20 or so. This consortium leads international efforts to understand T2D genetics 18372903 19060907 Dupuis et al, NG, in press Other outputs (not directly attributed to MRC funding) 19252133 19526209 18591388 18853133 19056611 19933169. The consortium is now (Oct 2011) preparing publications related to our activities with the metabochip, and on imputation from 1000Genomes into large GWA datasets.</gtr:impact><gtr:outcomeId>A5FC66319DA-2</gtr:outcomeId><gtr:partnerContribution>This is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>My group leads this international effort.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>deCODE genetics</gtr:collaboratingOrganisation><gtr:country>Iceland, Republic of</gtr:country><gtr:description>DIAGRAM (Diabetes Replication and Meta-analysis) consortium</gtr:description><gtr:id>EC933FC7-BD2F-4D34-B959-56387B1620C6</gtr:id><gtr:impact>In published work, we have identified ~12 novel T2D susceptibility genes, and in unpublished work (currently submitted or in press) a further 20 or so. This consortium leads international efforts to understand T2D genetics 18372903 19060907 Dupuis et al, NG, in press Other outputs (not directly attributed to MRC funding) 19252133 19526209 18591388 18853133 19056611 19933169. The consortium is now (Oct 2011) preparing publications related to our activities with the metabochip, and on imputation from 1000Genomes into large GWA datasets.</gtr:impact><gtr:outcomeId>A5FC66319DA-4</gtr:outcomeId><gtr:partnerContribution>This is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>My group leads this international effort.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stanford University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GTEX</gtr:description><gtr:id>70BAF3A9-C6BA-44B6-920C-B78D4A48EC71</gtr:id><gtr:impact>Several papers emerging including 24037378</gtr:impact><gtr:outcomeId>BCpz1JPckAs-3</gtr:outcomeId><gtr:partnerContribution>We have contributed analyses relating expresison data to GWAS signals</gtr:partnerContribution><gtr:piContribution>I lead one component of the analytical research related ot the GTEX project, as part of a recurrent R01 award held by PI Dermitzakis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ENGAGE (European Network for Genetic and Genomic Epidemiology)</gtr:description><gtr:id>03923D0B-6505-4C14-8114-D9781B47CCC6</gtr:id><gtr:impact>This supports large-scale data integration and has led to high profile publications and ongoing high profile research. Work arising has not had direct MRC funding but includes 19060911 19503597 19060910</gtr:impact><gtr:outcomeId>4C83ECBEAD7-1</gtr:outcomeId><gtr:partnerContribution>This supports large-scale data integration and has led to high profile publications and ongoing high profile research.</gtr:partnerContribution><gtr:piContribution>I co-lead this effort with Leena Peltonen of the SAnger,and following her death am the coordinator. It is funded by the EU (FP7)</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Aventis</gtr:department><gtr:description>DIRECT</gtr:description><gtr:id>805D3DAD-B20E-4BD1-A562-41AD0C579911</gtr:id><gtr:impact>Success in obtaining approx 45M? total funding (from the IMI and from pharma) for the DIRECT program of research from 2012 - 2018</gtr:impact><gtr:outcomeId>cPYVGFCzFm5-2</gtr:outcomeId><gtr:partnerContribution>Integrates our genetic and genomic appproaches with clinical resources to identify biomarkers able to support stratified medicine for T2D</gtr:partnerContribution><gtr:piContribution>This EU IMI grant is worth about ?45M. I was part of the writing committee for the final proposal and will lead on one of the major workpackages. The grant officially kicks off in 2012 but the collaboration started in 2010</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>H3Africa</gtr:description><gtr:id>594DE792-7F1D-4FFD-B6F8-A66B65158D59</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>AaKdzuG1CwJ-2</gtr:outcomeId><gtr:partnerContribution>We have designed and are now implementing a large collection of T2D cases and controls in Africa</gtr:partnerContribution><gtr:piContribution>I am part of the H3A funded project on diabetes in Africa.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Servier Laboratories</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>DIRECT</gtr:description><gtr:id>EDD50F18-F3EC-41DE-BD21-DF95B2CE9329</gtr:id><gtr:impact>Success in obtaining approx 45M? total funding (from the IMI and from pharma) for the DIRECT program of research from 2012 - 2018</gtr:impact><gtr:outcomeId>cPYVGFCzFm5-3</gtr:outcomeId><gtr:partnerContribution>Integrates our genetic and genomic appproaches with clinical resources to identify biomarkers able to support stratified medicine for T2D</gtr:partnerContribution><gtr:piContribution>This EU IMI grant is worth about ?45M. I was part of the writing committee for the final proposal and will lead on one of the major workpackages. The grant officially kicks off in 2012 but the collaboration started in 2010</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>DIAGRAM (Diabetes Replication and Meta-analysis) consortium</gtr:description><gtr:id>BA21AF47-605F-4EF8-8A8E-147EFE6ACD07</gtr:id><gtr:impact>In published work, we have identified ~12 novel T2D susceptibility genes, and in unpublished work (currently submitted or in press) a further 20 or so. This consortium leads international efforts to understand T2D genetics 18372903 19060907 Dupuis et al, NG, in press Other outputs (not directly attributed to MRC funding) 19252133 19526209 18591388 18853133 19056611 19933169. The consortium is now (Oct 2011) preparing publications related to our activities with the metabochip, and on imputation from 1000Genomes into large GWA datasets.</gtr:impact><gtr:outcomeId>A5FC66319DA-7</gtr:outcomeId><gtr:partnerContribution>This is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international collaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activityThis is a large international colaboration that has enabled large-scale association studies in T2D resulting in several publications and ongoing high profile research activity</gtr:partnerContribution><gtr:piContribution>My group leads this international effort.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>F. Hoffmann-La Roche AG</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>SUMMIT</gtr:description><gtr:id>CFC860F5-5F10-4F40-B0E9-2E9D277C7EDD</gtr:id><gtr:impact>Tangible ouput is 30M euros of funding from EU and pharma
Publications 2013</gtr:impact><gtr:outcomeId>EB096D4A910-3</gtr:outcomeId><gtr:partnerContribution>This project is funded by EU-IMI. WE lead WP1, have analysed most of teh GWAS data and performed and analysed exome sequencing data. Publications anticipated 2013.</gtr:partnerContribution><gtr:piContribution>I am one of the leaders of the consortium with responsiblity specifically for the GWA studies of diabetes complciations at the core of the proposal. It has been funded to a total of ?28M by the EU and EFPIA partners under the IMI initiative</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Genomics for Clinicians meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E574E6F2-C5B7-43C1-AE37-51C854ADE466</gtr:id><gtr:impact>I gave a presentation at this 4 day workshop on the value of diabetes genetics in genomic medicine</gtr:impact><gtr:outcomeId>58c55c0feb7fa6.81957599</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Personalised medicine Symposium, Bastad Sweden</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9B70E084-2158-43D5-AE42-2556A592CE61</gtr:id><gtr:impact>Part of a symposium on Personalised Medicine held in Sweden</gtr:impact><gtr:outcomeId>58c55cbef3f5f5.27131399</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>East Meets West Conference Hong Kong</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E8B493F8-A39A-48CB-83B6-3A6BE8434E6E</gtr:id><gtr:impact>Lecture, debates, discussions about diabetes genetics in East Asia and beyond</gtr:impact><gtr:outcomeId>58c55d0b5e0c16.81933708</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust - Journalists</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7545C461-5AF7-4C42-A7CF-1296BEF77400</gtr:id><gtr:impact>Lectures to and meetings with science journalists. In addition, frequent contacts with national and international journalists to comment on stories, provide quotes etc

Newspapers, online media, radio, quotes, articles</gtr:impact><gtr:outcomeId>94AA4BDFD3B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007,2009,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cafe Scientifique - Exeter</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>09DF1BFA-0584-448F-A0CB-254ABE3C3A99</gtr:id><gtr:impact>A 40-45 minute presentation to a lay audience followed by 45 minutes of questions and answers. This was mainly around the &amp;quot;fat gene&amp;quot; story, but all aspects of human genetics were discussed.

There was lots of interest from the audience who asked plenty of searching questions! A member of the audience interviewed me for a piece in Devon Country Life magazine, which increased the impact of the research.</gtr:impact><gtr:outcomeId>1C94AEDE347</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NovoNordisk Workshop on Early Growth genetics</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4509F23E-0E91-4F3F-887F-DAF7E8701F3F</gtr:id><gtr:impact>Part of a discussion about the role of genes and environment on the relationship between early growth and later metabolic disease</gtr:impact><gtr:outcomeId>58c55c6cc488c1.29195318</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Short article in study participants' newsletter.</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FA118B6B-1238-42C0-A393-EB86ED6AE24D</gtr:id><gtr:impact>Short articles describing our research on diabetes and birth weight genes aimed at patients and research volunteers who had contributed DNA and phenotype information from themselves and in some cases, their offspring.

A greater understanding of genetic research by the study participants - in Exeter we have successfully recruited a large number of individuals to genetic studies. Virtually no-one declines to take part in a study on the grounds that they are suspicious of genetic research. Although hard to prove we hope that our &amp;quot;user-friendly&amp;quot; dissemination is part of the reason for this success.</gtr:impact><gtr:outcomeId>618FD264FB6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diabetes UK patient and volunteer conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9EE30EA7-119D-4D34-9260-079534598B9C</gtr:id><gtr:impact>A presentation followed by question and answer session to &amp;gt;300 Diabetic patients and fundraisers at their annual conference in Manchester, October 2009. I was the only presenter invited to talk about type 2 diabetes related research, along with one presenter invited to talk about type 1 diabetes.

Considerable interest in the question and answer session. Hopefully an improved understanding by the patients of what we learn from their DNA samples.</gtr:impact><gtr:outcomeId>A3A0F6CFE20</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pint of Science</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DEEAF1F3-B081-41C7-B28C-4A8A877E2819</gtr:id><gtr:impact>A talk on obesity genetics at a local pub. &amp;quot;Pint of Science&amp;quot; was sponsored by the Wellcome Trust and eLIFE</gtr:impact><gtr:outcomeId>58c02171a57d09.66322901</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DNA testing: &quot;Science or Swindle?&quot;</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>49726A6B-69EC-4AF5-BC3C-DE4C53464B40</gtr:id><gtr:impact>This was a public seminar hosted by the DANA centre at the Science Museum, London. I was one of four scientists giving a brief presentation followed by four question and answer sessions. The topic was direct to consumer DNA tests that companies such as DecodeMe and 23andMe are offering.

Lots of questions and comments from a lay audience. For myself, an improved understanding of the public's perceptions of human genetics. For the public, hopefully an improved understanding of human genetics.</gtr:impact><gtr:outcomeId>37151F34C8C</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Personalised genomics</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>08C863E0-579C-4398-B9E8-0C6D12910298</gtr:id><gtr:impact>Public debate; conference presentations

Improved understanding of the issues by the audience</gtr:impact><gtr:outcomeId>30D89C026CD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2012,2013,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Progress Education Trust</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BD2660A6-A80E-4BBA-9145-68827A11428B</gtr:id><gtr:impact>Workshop/Seminar on hype in genetics

discussions, followup contacts</gtr:impact><gtr:outcomeId>CDDF9482C92</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diabetes UK patients and fundraisers</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8924D690-E819-4265-B610-53C3908B87DF</gtr:id><gtr:impact>Presentation adn QandA session to diabetes patients and fundraisers at the DIabetes UK annual conference.

Interest from audience and further invites to other groups</gtr:impact><gtr:outcomeId>31843CEC5A5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust - Artists</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C9760E41-1FD1-4883-A5D8-741199B86061</gtr:id><gtr:impact>Describing genetic research to artists and those in visual media interesting in applying to Wellcome Trust Arts-related funding

Informed projects submitted to WT for funding</gtr:impact><gtr:outcomeId>294A068C867</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientific presentations and seminars</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C7A39A93-4F45-4025-AD9E-7317E824DF04</gtr:id><gtr:impact>Data from these two grants has been presented at a large number of international meetings including American Diabetes Association, American Soc Human Genetics, Genomics of Common Diseases and other meetings (approx 20 a year)

Large audiences</gtr:impact><gtr:outcomeId>j4sRXgWF8X3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2013,2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>129000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>6B72884D-BDE3-4E35-A867-FB75E3F164A0</gtr:id><gtr:outcomeId>SHpejmcGw4V0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>U01</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</gtr:fundingOrg><gtr:fundingRef>DK105535</gtr:fundingRef><gtr:id>75D11CC3-D98E-4F4A-84B1-62A3A0F84070</gtr:id><gtr:outcomeId>56db0e17af7311.23177741</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2400000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>NIH R01</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</gtr:fundingOrg><gtr:fundingRef>DK098032</gtr:fundingRef><gtr:id>DA5478ED-B7A2-4B26-A80D-042C91D26DEC</gtr:id><gtr:outcomeId>A2MFxoo5aSk</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Innovative Medicines Initiative (IMI)</gtr:department><gtr:description>Innovative Medicines Initiative BEATDKD</gtr:description><gtr:end>2022-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>BEATDKD</gtr:fundingRef><gtr:id>771CA817-3166-41EE-86A5-821344010402</gtr:id><gtr:outcomeId>58c55af3987064.66652555</gtr:outcomeId><gtr:sector>Multiple</gtr:sector><gtr:start>2017-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>791000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Career Development Fellowship</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>03A5F603-DEE3-410A-911C-336BCCE7418F</gtr:id><gtr:outcomeId>B80EE62E0BA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>16006928</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Strategic Award</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>4968FB16-7AEF-46E9-8A0B-B164B2F2B02D</gtr:id><gtr:outcomeId>eCSKjMnrA4M0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU Innovative Medicines Initiative DIRECT project (40m euros across 20 participants)</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>A5AE31D3-77EB-4D44-A33F-A45815EFC8B2</gtr:id><gtr:outcomeId>nipGabGtM6b0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>214000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK, Project Grant Using human genetics to understand the role of adiponectin in type 2 diabetes and insulin resistance.</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>A27661E3-0DDF-4FC3-9F50-BDDDFE7332F7</gtr:id><gtr:outcomeId>4CD475966860</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>868000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project GRant</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>83B2D3FF-CBA8-4E4A-8D65-8020A1D10E6E</gtr:id><gtr:outcomeId>rJ6JNdHiAZE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>502000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>22B24DA0-3661-457C-B583-FE47DE2AC799</gtr:id><gtr:outcomeId>FCB0DAF00140</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>378462</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ENGAGE European network for genetic and genomic epidemiology (12m euros across 26 participants)</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>84AA314D-39FA-4BF2-B217-1298FAEDA799</gtr:id><gtr:outcomeId>GTbDr49xrsN0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>129000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK, Clinical Training Fellowship</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>7DA3DF9F-708B-4057-A20D-4397B0A7F211</gtr:id><gtr:outcomeId>5FDE916F6CA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2592923</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Strategic Award (Next-Generation Disease Association Analyses: Low pass Sequencing and High Density SNP genotyping for type 2 diabetes)</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>74DD841C-AC7F-4120-BC0A-1871E434C97A</gtr:id><gtr:outcomeId>76A89F46DD10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>217000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPI-MIGRANT Identification of epigenetic markers underlying increased risk of T2D in South Asians (3m euros across 12 participants)</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>37E20523-0258-4961-B978-70B86835A08C</gtr:id><gtr:outcomeId>N9NZiAUJ6P20</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Innovative Medicines Initiative (StemBANCC)</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>36DFD202-20CF-45A9-825C-A5AF2FF00EBF</gtr:id><gtr:outcomeId>UU1LvXhHCeX</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>72000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Studentship</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>6D167CEF-99E5-4BB8-9C82-4565DC1A8EDC</gtr:id><gtr:outcomeId>GuDLuDogG2e0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>440000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>5C461BAB-B3ED-4303-9AFB-2C267416BC51</gtr:id><gtr:outcomeId>Ty59v3Sw82R0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Henry Wellcome Fellowships</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9C4F4E7F-8C92-4B8E-888D-EFF5889BE7AA</gtr:id><gtr:outcomeId>142B9C612B30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>98000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CASE</gtr:description><gtr:end>2021-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/P016065/1</gtr:fundingRef><gtr:id>1313292C-0BBC-4FBF-9604-A52A410D5B43</gtr:id><gtr:outcomeId>58c01bfe34e5d8.40102930</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>142000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK project grant</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>4876D5A5-D309-4859-8BE7-E05C3D0761E5</gtr:id><gtr:outcomeId>fmVX2GmmkkU0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>U01 award</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>7CD15792-FE86-44E8-A8FD-DEEDC8C937C2</gtr:id><gtr:outcomeId>BCEEBA415580</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>401000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Using genetics to understand sleep and chronotype and their relationship to obesity and type 2 diabetes.</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DC86B46D-EF14-4324-B60E-94A65E55FC0A</gtr:id><gtr:outcomeId>58c01cfd4cd122.08379370</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:department>National Institute of Mental Health (NIMH)</gtr:department><gtr:description>NIH R01</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>MH101814</gtr:fundingRef><gtr:id>9CFCC35F-7611-4D0B-913E-2907BDB8CC23</gtr:id><gtr:outcomeId>HBuVnPqPxJK</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant (KlF14)</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8A1BAC68-348F-4E1B-B3C8-77AED4066765</gtr:id><gtr:outcomeId>HBtu2h8CZa9</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>172389</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes and Wellness Foundation fellowship for Jessica Tyrrell</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>The Diabetes Research &amp; Wellness Foundation</gtr:fundingOrg><gtr:id>BCB8303A-58A4-4054-B330-92FF5C9BD2EE</gtr:id><gtr:outcomeId>58c01ec1ebc2f1.80715593</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Program grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9461458F-19F8-4206-8140-BF74532D966C</gtr:id><gtr:outcomeId>545e9fa9db9421.11292959</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>178000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK, Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>E870DB95-E195-496F-ACAD-E58C942B5F55</gtr:id><gtr:outcomeId>5530CFD41D10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14000000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Grand opportunity grants</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>F9348149-3522-44F2-8557-D53375B1A1FC</gtr:id><gtr:outcomeId>BCFE9BDBB260</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Innovative Medicines Initiative (IMI)</gtr:department><gtr:description>Innovative Medicines Initiative RHAPSODY</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>9B136675-97FD-4DA4-81A4-CD9DE4FC489C</gtr:id><gtr:outcomeId>58c55a888a4ed2.39498570</gtr:outcomeId><gtr:sector>Multiple</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12000000</gtr:amountPounds><gtr:country>Denmark, Kingdom of</gtr:country><gtr:currCode>DKK</gtr:currCode><gtr:currCountryCode>Denmark</gtr:currCountryCode><gtr:currLang>da_DK</gtr:currLang><gtr:department>Novo Nordisk Foundation</gtr:department><gtr:description>NovoNordisk Funden Immunometabolism</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>Novo Nordisk</gtr:fundingOrg><gtr:fundingRef>TRiiC</gtr:fundingRef><gtr:id>981B8BE6-F602-4E43-A9FE-EDFEBAB3BF67</gtr:id><gtr:outcomeId>58c55b4b54cdf0.51595959</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Henry Dale award to Rachel Freathy</gtr:description><gtr:end>2021-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>7355101D-6AB8-4A93-A054-8D49C8D15CE5</gtr:id><gtr:outcomeId>58c023d28735d3.30573090</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SUMMIT SUrrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools (28.4m euros across 23 participants)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>A1481BD7-4401-4DB5-A3CD-53978C6E125C</gtr:id><gtr:outcomeId>CKwpVfgqS5i0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator Award</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>67305C08-3E15-47C6-9170-CCC5BB2A3CD1</gtr:id><gtr:outcomeId>VbWMDvRKgtK</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>JDRF Special Award</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Juvenile Diabetes Research Foundation (JDRF)</gtr:fundingOrg><gtr:id>4E8C8A51-ACBD-4FBF-AAC2-E6C9646D81C3</gtr:id><gtr:outcomeId>545e9f561fd282.13873338</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>205000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CEED3 Collaborative European effort to develop diabetes diagnostics (3m euros across 12 participants)</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>E8FD93D3-8E39-4BAD-97A8-229572E38AE8</gtr:id><gtr:outcomeId>gGE9h5rDjUb0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>212000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>14821B85-2EDA-4703-B830-707232B3A7AB</gtr:id><gtr:outcomeId>E2E68F8CBE60</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We have contributed (using MRC funds wholy or in part) to identification of many genes influencing T2D, BMI and other related phenotypes (see publications). We regard these discoveries as pre competitive (in line with NIH and other recommendations) and have DELIBERATELY chosen not to seek protection. We regard protection of such discoveries as counter productive from the point of view of biological and translational advance.</gtr:description><gtr:grantRef>G0601261</gtr:grantRef><gtr:id>F259E6B5-65EB-453B-83A9-9E8C604C69A1</gtr:id><gtr:impact>We believe that by sharing these findings as early as possible through publication and without any protection that we support rapid scientific progression and future translational usage.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>D47B4D2050A</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>~150 common variant signals underlying common diseases</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>House of Lords Enquiry into genetic Medicine</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>46F15493-DA86-44D4-82DC-FCA5458E5751</gtr:id><gtr:outcomeId>C23CC81F0E3</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Genome Quebec Advisory Board</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>7842C09A-42BB-4EA2-B5BF-95438E90C0AA</gtr:id><gtr:outcomeId>PLcsQny9cdt</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chief Medical Officers Genomics Advisory Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>44837272-78B6-45FD-9633-5B0A72A31673</gtr:id><gtr:outcomeId>jdmSRCCMsPb</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>extensive citation of our work in clinical reviews</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E7026D70-1139-453A-AE5C-1B5BCE12193B</gtr:id><gtr:outcomeId>A8554DB9267</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIH Target Validation Committee (Diabetes)</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>660DE61A-FC68-43BC-B593-F3D9A286E982</gtr:id><gtr:impact>Designing private-public partnership between NIH and pharma to develop Target Validation Consortium</gtr:impact><gtr:outcomeId>CsuinJw2QZg</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Human Genetics Commission</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>231FEA73-7E87-45AF-8D9E-9531A10AE57E</gtr:id><gtr:outcomeId>716378C00FF</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Knowledge portal containing diverse T2D genetic data contributed by multiple groups. In beta-testing. Soft launch early 2015</gtr:description><gtr:id>9071C7F0-EDAF-4F01-A261-E00CB674866A</gtr:id><gtr:impact>HAs attracted attention from pharma contribting to development of Accelerating Medicines Partnership between NIH and pharma in the US, now funidng further development of this portal</gtr:impact><gtr:outcomeId>545ea12fbf4474.40264959</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DIabetes Knowledge Portal</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Exome array data at both summary and individual data level. Former widely available, latter via EGA</gtr:description><gtr:id>363D5ECC-13D3-4A5D-8621-5DB3F000ED41</gtr:id><gtr:impact>Has contributed to several publications from diverse groups</gtr:impact><gtr:outcomeId>545ea0cef180c4.50278891</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>UK exome array</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Contributed to design of Illumina and Affymetrix exome arrays - total sales value of products ~$100,000,000 to date.</gtr:description><gtr:id>814AD03C-B4ED-4212-A503-01C5C6899A63</gtr:id><gtr:impact>Used to support design of commercial arrays</gtr:impact><gtr:outcomeId>m344EoeMgjY</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Exome chip design</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Through the MRC grant, as well as many of our other funded grants, we have contributed to the development of methodology (and in several cases software - though the software was developed under other funding) to support these studies.</gtr:description><gtr:id>B0875073-15DA-47B2-AD89-FDE4794E1DD9</gtr:id><gtr:impact>See publications</gtr:impact><gtr:outcomeId>A5E60BF39ED</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genome wide meta-analysis infrastructure</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Custom iSELECT array for fine mapping and replication of cardiometabolic traits</gtr:description><gtr:id>AAC99F90-6720-4E4B-A733-35FD3F1DD6F5</gtr:id><gtr:impact>Has been typed on over 200,000 samples so far - publications emerging in coming months</gtr:impact><gtr:outcomeId>dWopUZKWMSn</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Metabochip</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have contirbuted in many international consortia to the development of combined data sets (e.g. GIANT - 150,000 samples with genome wide association data) that provide powerful tools for exploration of the genetics of common disease</gtr:description><gtr:id>FCED854F-F840-42C2-AEFB-EE643EA7B85E</gtr:id><gtr:impact>See publication list e.g. ~10 papers in high impact journals in the past couple of years or so</gtr:impact><gtr:outcomeId>C7EE93D843D</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genome wide meta-analysis data sets</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We were involved in design and testing of the new Illumina Omni2.5M array</gtr:description><gtr:id>3B2ECD6D-407F-4662-8E31-CDA7B3EEE653</gtr:id><gtr:impact>Commercialised by Illumina.</gtr:impact><gtr:outcomeId>tdF7S4z5WpJ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>High density arrays</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>00990C17-8E7D-4355-9AE7-8BC99CBAEB7C</gtr:id><gtr:title>Transcriptome and genome sequencing uncovers functional variation in humans.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9e3b17f04dabf38bf53a4529d1e7dbd"><gtr:id>d9e3b17f04dabf38bf53a4529d1e7dbd</gtr:id><gtr:otherNames>Lappalainen T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>Fz9jDZdV1e5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF7B4628-AB5F-48D6-A1ED-92F351AE7D45</gtr:id><gtr:title>Genetic studies of body mass index yield new insights for obesity biology.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b2ba3cf7428e3cca65709eeacf5d199"><gtr:id>5b2ba3cf7428e3cca65709eeacf5d199</gtr:id><gtr:otherNames>Locke AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56c0ec27ea3198.14569627</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72EEA5A3-0B00-4307-9FEE-601B7DD4AAE4</gtr:id><gtr:title>Variants in MTNR1B influence fasting glucose levels.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8619aabd857174cb3a1267c70922af4b"><gtr:id>8619aabd857174cb3a1267c70922af4b</gtr:id><gtr:otherNames>Prokopenko I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>BC40DDDD82F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7408F6A-8369-4168-93FC-F740D0112F51</gtr:id><gtr:title>Age-related clonal hematopoiesis associated with adverse outcomes.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/386c092ffdc8ae1005263f63637cb54e"><gtr:id>386c092ffdc8ae1005263f63637cb54e</gtr:id><gtr:otherNames>Jaiswal S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>doi_55f98498417f414b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20A98F0C-C1EA-47D4-886E-7C38A82177AE</gtr:id><gtr:title>The genetic architecture of type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02f1c0ac4ac1ce215e6ad458834e0672"><gtr:id>02f1c0ac4ac1ce215e6ad458834e0672</gtr:id><gtr:otherNames>Fuchsberger C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>585d662f417fa8.75632934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8227D523-9874-42FA-AA24-851E5819C8C8</gtr:id><gtr:title>Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ca27e0a17db7a6e86f7f822fcb4823b"><gtr:id>0ca27e0a17db7a6e86f7f822fcb4823b</gtr:id><gtr:otherNames>Perry JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>E9B58300EF3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF32B557-A6D4-4A39-B884-D85F34F181FF</gtr:id><gtr:title>Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ca27e0a17db7a6e86f7f822fcb4823b"><gtr:id>0ca27e0a17db7a6e86f7f822fcb4823b</gtr:id><gtr:otherNames>Perry JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_13659_29_22693455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB50BDAC-16AE-4E22-8115-1FE2B3CF0632</gtr:id><gtr:title>Gene-targeted analysis of copy number variants identifies 3 novel associations with coronary heart disease traits.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b50aee744b8b585f49b0928b2ccaa298"><gtr:id>b50aee744b8b585f49b0928b2ccaa298</gtr:id><gtr:otherNames>Costelloe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>doi_55f984984193a841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75A533F2-77A2-4392-B7FB-CC59279204C4</gtr:id><gtr:title>Genome-wide association study of primary tooth eruption identifies pleiotropic loci associated with height and craniofacial distances.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e3982bc211a216e6acdb992a1854482"><gtr:id>6e3982bc211a216e6acdb992a1854482</gtr:id><gtr:otherNames>Fatemifar G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>doi_55f9849841894fd3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF318199-0546-4336-B41E-FDFDC6938104</gtr:id><gtr:title>Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2585f667011ac6b4b6067f3daa12542"><gtr:id>a2585f667011ac6b4b6067f3daa12542</gtr:id><gtr:otherNames>Willer CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>755BCE5D055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>570693CB-C860-4357-968A-4FF59FA3E3C0</gtr:id><gtr:title>Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27809cc0a8e4f9882edef5b9c8317d11"><gtr:id>27809cc0a8e4f9882edef5b9c8317d11</gtr:id><gtr:otherNames>Zeggini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>F7B0A961E63</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C00BF590-4E38-4C03-BDF3-2FE0AD5F4500</gtr:id><gtr:title>New genetic loci link adipose and insulin biology to body fat distribution.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a085b336b6081bf206928f3cdcb91748"><gtr:id>a085b336b6081bf206928f3cdcb91748</gtr:id><gtr:otherNames>Shungin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56c0ec2a91f285.89105406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3488650C-F942-4C68-8570-32164DF3B4A8</gtr:id><gtr:title>Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abe4d724bb5444487ff8158226a1e3de"><gtr:id>abe4d724bb5444487ff8158226a1e3de</gtr:id><gtr:otherNames>Heid IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>WGNP12CLdiL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47079230-9849-44ED-9C9E-14A94145BE34</gtr:id><gtr:title>Linkage disequilibrium mapping of the replicated type 2 diabetes linkage signal on chromosome 1q.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8619aabd857174cb3a1267c70922af4b"><gtr:id>8619aabd857174cb3a1267c70922af4b</gtr:id><gtr:otherNames>Prokopenko I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>A63D3DDD14D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>747A0719-2749-4848-9C0B-B971CA3DC32B</gtr:id><gtr:title>Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90eaab64ef82e6d388d056fda37c0027"><gtr:id>90eaab64ef82e6d388d056fda37c0027</gtr:id><gtr:otherNames>Speliotes EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>T7YfbJoV9NT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>374CAB3A-B66C-4B89-9635-1BC646C2AB56</gtr:id><gtr:title>Quantifying the extent to which index event biases influence large genetic association studies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c89be373aae853cd567a545d75230ff"><gtr:id>8c89be373aae853cd567a545d75230ff</gtr:id><gtr:otherNames>Yaghootkar H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58c00e8cf12de3.56358728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B729866D-C50A-4C49-8314-0DA0D2DAF3D8</gtr:id><gtr:title>Large-scale association analysis identifies new risk loci for coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f10abe080ea072f120714f3fbee29092"><gtr:id>f10abe080ea072f120714f3fbee29092</gtr:id><gtr:otherNames>CARDIoGRAMplusC4D Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>nXpeE6WGSwy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41403E63-FEB9-46B0-9BAC-732A01922FE4</gtr:id><gtr:title>Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e58394649297bcf1ab285b4dfd88ec77"><gtr:id>e58394649297bcf1ab285b4dfd88ec77</gtr:id><gtr:otherNames>Palmer CN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13659_29_22724004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA958E60-4831-4BCA-8DAF-254453AF845E</gtr:id><gtr:title>A Low-Frequency InactivatingVariant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2407777c73110f2180165c0df3740fac"><gtr:id>2407777c73110f2180165c0df3740fac</gtr:id><gtr:otherNames>Manning A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>5a34f38b1f3429.58311612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>097AFD42-624A-4500-B23C-6B14A743B9CF</gtr:id><gtr:title>Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8e6a2e397f73af486c45cfc32c68678"><gtr:id>e8e6a2e397f73af486c45cfc32c68678</gtr:id><gtr:otherNames>Knowles JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>58c00e8f1e5ba5.91655726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9C4B1A4-EE47-4182-8A0A-813C10A7CC8E</gtr:id><gtr:title>Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07f821046a15bbd1b7e1e58e84710919"><gtr:id>07f821046a15bbd1b7e1e58e84710919</gtr:id><gtr:otherNames>Tyrrell J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>58c00e8ed747d3.66332266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85C079A9-9C72-4A44-BE7B-7036FC56534F</gtr:id><gtr:title>Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf701a8f3e746fa6cdbab8e1399f7fb8"><gtr:id>bf701a8f3e746fa6cdbab8e1399f7fb8</gtr:id><gtr:otherNames>Randall JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>545e9651548db4.86029387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19A1BE27-4128-4575-8B7A-404276E9FB8F</gtr:id><gtr:title>Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4069f6f80abc3dca900b1ffc9ba77f6f"><gtr:id>4069f6f80abc3dca900b1ffc9ba77f6f</gtr:id><gtr:otherNames>Scott RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>545e9654e718e5.64416754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BB639A5-E7C7-46A7-84BC-68D6012CA5F0</gtr:id><gtr:title>Transancestral fine-mapping of four type 2 diabetes susceptibility loci highlights potential causal regulatory mechanisms.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95ce9b9b8fd10225d3aa14853e1462a1"><gtr:id>95ce9b9b8fd10225d3aa14853e1462a1</gtr:id><gtr:otherNames>Horikoshi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58c5566b01efb8.82382598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3322398E-477D-4051-B190-EFCB17ED2AFB</gtr:id><gtr:title>Hundreds of variants clustered in genomic loci and biological pathways affect human height.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4373f03a5361b2f4b27d2e547bdf341"><gtr:id>f4373f03a5361b2f4b27d2e547bdf341</gtr:id><gtr:otherNames>Lango Allen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>MvqjuNbNRRF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C32EE43B-EC5D-4B22-8620-3CB9B4A0D4F8</gtr:id><gtr:title>An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4069f6f80abc3dca900b1ffc9ba77f6f"><gtr:id>4069f6f80abc3dca900b1ffc9ba77f6f</gtr:id><gtr:otherNames>Scott RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>5aa6fa731b7e80.31207541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7209A968-6CDE-480F-B09A-DEB5E5E87D1D</gtr:id><gtr:title>Analysis of protein-coding genetic variation in 60,706 humans.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0502195b3d1a521f69e91ecf1cb5cef6"><gtr:id>0502195b3d1a521f69e91ecf1cb5cef6</gtr:id><gtr:otherNames>Lek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>585d4fb311e457.24894287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADAB3EAD-F752-4F1C-8050-273B3FB94E0D</gtr:id><gtr:title>Authors' reply to Toth.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44503bb925ae8ff7743eb6ed79a62ecc"><gtr:id>44503bb925ae8ff7743eb6ed79a62ecc</gtr:id><gtr:otherNames>Frayling TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>58c00e8e206c10.85369595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2CF70FF-B2FA-4190-A286-B04911F118C1</gtr:id><gtr:title>Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/911a497a2ffc637d599244fdd0cfdabc"><gtr:id>911a497a2ffc637d599244fdd0cfdabc</gtr:id><gtr:otherNames>Lindgren CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>457ECA2D90C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DDF7E3E-EEFD-4C4D-81CC-12A4D09A33E7</gtr:id><gtr:title>Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/759abf23b68d9e9b3d4f70e43a65ce63"><gtr:id>759abf23b68d9e9b3d4f70e43a65ce63</gtr:id><gtr:otherNames>Morris AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13659_29_22885922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B6F94E6-5E14-45D0-9C3C-9AFAB28C13D2</gtr:id><gtr:title>Type 2 diabetes: new genes, new understanding.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8619aabd857174cb3a1267c70922af4b"><gtr:id>8619aabd857174cb3a1267c70922af4b</gtr:id><gtr:otherNames>Prokopenko I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>9860A8A0027</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47A72104-98ED-4FA0-9284-5C0BA5F03AC1</gtr:id><gtr:title>Variants in the FTO and CDKAL1 loci have recessive effects on risk of obesity and type 2 diabetes, respectively.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5c7dfb7949253c2a1b684d1952ae3ac"><gtr:id>d5c7dfb7949253c2a1b684d1952ae3ac</gtr:id><gtr:otherNames>Wood AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>58c00e8e9f4ae9.76887963</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B9D5860-A293-4316-9DB7-68438B67EF1D</gtr:id><gtr:title>Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc5497d6ba338db75e3147b30ba3daf9"><gtr:id>bc5497d6ba338db75e3147b30ba3daf9</gtr:id><gtr:otherNames>Freathy RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>CgSuMyESPCN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D8450B3-9B5D-4C27-B3DC-93765493898A</gtr:id><gtr:title>Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants?</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b893adad41a6bf1bc45c87ef37eac4bb"><gtr:id>b893adad41a6bf1bc45c87ef37eac4bb</gtr:id><gtr:otherNames>Southam L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>AB545D3D37D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6101CEB3-7DD7-49CE-ADED-2D22E4EE980B</gtr:id><gtr:title>Assessing association between protein truncating variants and quantitative traits.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bd098697bd70f44f21e158259d0b6f4"><gtr:id>1bd098697bd70f44f21e158259d0b6f4</gtr:id><gtr:otherNames>Rivas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>YNtUZ8xVaf3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13E0B186-A42B-481E-9685-93FBC491BA0A</gtr:id><gtr:title>New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/695b1fb9d910198e8ecc013960e72c2f"><gtr:id>695b1fb9d910198e8ecc013960e72c2f</gtr:id><gtr:otherNames>Dupuis J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>gfAGvKYsBFt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A861312C-C9A5-4BEE-AD66-DF7532CD4441</gtr:id><gtr:title>Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fd3cc7d5807a18dec29f22b0fc45336"><gtr:id>6fd3cc7d5807a18dec29f22b0fc45336</gtr:id><gtr:otherNames>Voight BF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>Kj4ibpRzkEQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F440BD4D-362B-4E27-96B9-FF5161D5CAF2</gtr:id><gtr:title>A reference panel of 64,976 haplotypes for genotype imputation.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce03a107f4b996d7c5ae67ea37026325"><gtr:id>ce03a107f4b996d7c5ae67ea37026325</gtr:id><gtr:otherNames>McCarthy S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58c556690b1c74.03562267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6FF66B4-DBF5-4546-A0DA-BE01D9B48440</gtr:id><gtr:title>The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3910f4e5f22b59f0f4314fa19d594e18"><gtr:id>3910f4e5f22b59f0f4314fa19d594e18</gtr:id><gtr:otherNames>InterAct Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_13659_29_23052052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>410DB23B-DE8D-4093-ABA2-83C8B37EBA65</gtr:id><gtr:title>Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2c39afe845e351135709b4da8652d2f"><gtr:id>f2c39afe845e351135709b4da8652d2f</gtr:id><gtr:otherNames>Berndt SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>BPMgbDnKP7P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBF43E78-07A6-44FA-8378-127888291B22</gtr:id><gtr:title>Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bbac37c4f86588c8e289e41409751c3"><gtr:id>2bbac37c4f86588c8e289e41409751c3</gtr:id><gtr:otherNames>Strawbridge RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>fEojtTvGTfY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BBB0FF7-3AF6-4FD0-AC0D-F336C3511FEC</gtr:id><gtr:title>Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8d0d707058e00bf23ad82c432298457"><gtr:id>a8d0d707058e00bf23ad82c432298457</gtr:id><gtr:otherNames>Mahajan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>doi_55f9849841a01b2c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D2F2EEB-B29D-4B8A-BB24-AC19F35685AF</gtr:id><gtr:title>Sequence data and association statistics from 12,940 type 2 diabetes cases and controls.</gtr:title><gtr:parentPublicationTitle>Scientific data</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cb0b293ccd2349b5426b0bad94b6309"><gtr:id>0cb0b293ccd2349b5426b0bad94b6309</gtr:id><gtr:otherNames>Flannick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2052-4463</gtr:issn><gtr:outcomeId>5aa6fa9f3ea389.74801410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFEFDFE4-3AFB-426B-ADA3-34B499D4640B</gtr:id><gtr:title>A central role for GRB10 in regulation of islet function in man.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8619aabd857174cb3a1267c70922af4b"><gtr:id>8619aabd857174cb3a1267c70922af4b</gtr:id><gtr:otherNames>Prokopenko I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>545e99a4820867.12207699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B93FBDEF-5955-4A64-8C6E-E103C1FF7BA2</gtr:id><gtr:title>A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3229db201f0ecfaec7eff515892210da"><gtr:id>3229db201f0ecfaec7eff515892210da</gtr:id><gtr:otherNames>Ried JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58c55666d8f395.26626677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B7D6081-ED66-492E-932E-CB36833FEAB1</gtr:id><gtr:title>The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f460767649781454eba53de21a508d00"><gtr:id>f460767649781454eba53de21a508d00</gtr:id><gtr:otherNames>Ehret GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58c556686ec570.12848991</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87BBD693-94F8-4E0A-A1D7-4A28AD175CE6</gtr:id><gtr:title>Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de41c11b550899302b03fb463d7aa4bc"><gtr:id>de41c11b550899302b03fb463d7aa4bc</gtr:id><gtr:otherNames>Langenberg C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>545e99a45c5f04.41776114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4D5507E-D47F-4A18-B78A-B97F5D720F5D</gtr:id><gtr:title>Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2822ecb2ba9c0b6217bfd001aa570c4b"><gtr:id>2822ecb2ba9c0b6217bfd001aa570c4b</gtr:id><gtr:otherNames>Xie W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>doi_55f9849841a8ab24</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C8C34AB-7A63-4E76-BE93-B6B248758570</gtr:id><gtr:title>Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.</gtr:title><gtr:parentPublicationTitle>Clinical pharmacology and therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c56a4604761c5360383524ffc595c8e4"><gtr:id>c56a4604761c5360383524ffc595c8e4</gtr:id><gtr:otherNames>Donnelly LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-9236</gtr:issn><gtr:outcomeId>pm_13659_29_21178985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EA9DDDF-5461-4620-BFD1-1F6FD64A7C22</gtr:id><gtr:title>The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c969b7adc99141cd24dafb66e939664d"><gtr:id>c969b7adc99141cd24dafb66e939664d</gtr:id><gtr:otherNames>'t Hart LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>doi_55faa1aa1bada676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7047A3FC-ED1C-457A-9DC5-E727278A1C95</gtr:id><gtr:title>New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95ce9b9b8fd10225d3aa14853e1462a1"><gtr:id>95ce9b9b8fd10225d3aa14853e1462a1</gtr:id><gtr:otherNames>Horikoshi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>UvtcpnHPYRF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7508FE1-A61D-4882-BFE6-E665049400DF</gtr:id><gtr:title>Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6e74fe070d8ab2a2013446adf8395c9"><gtr:id>e6e74fe070d8ab2a2013446adf8395c9</gtr:id><gtr:otherNames>DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>545e99a4329465.57976137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7733FDF8-985C-4D43-869A-336F8B51F981</gtr:id><gtr:title>Re-sequencing expands our understanding of the phenotypic impact of variants at GWAS loci.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0f685d617ca9a007fa97b604c8a8bb7"><gtr:id>c0f685d617ca9a007fa97b604c8a8bb7</gtr:id><gtr:otherNames>Service SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>545e96551f3ce9.17609131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60803E0F-4632-48E3-B26B-30BB030AF4BA</gtr:id><gtr:title>Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bb7a6de840de3e9259cbb1e22c65ea1"><gtr:id>3bb7a6de840de3e9259cbb1e22c65ea1</gtr:id><gtr:otherNames>Zhou K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>545e9655d92c46.88361306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17E933B2-DF1D-4E99-965C-503E83FA2CC6</gtr:id><gtr:title>Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/372a17a19f0aa4ad420ec523b27f31e2"><gtr:id>372a17a19f0aa4ad420ec523b27f31e2</gtr:id><gtr:otherNames>Gaulton KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56c0ec25a5a9e9.17740490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25FBBF00-DD8B-4965-A5EC-22F04D2A7551</gtr:id><gtr:title>Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4624f6fd2a56312abc4fac99ff1b213b"><gtr:id>4624f6fd2a56312abc4fac99ff1b213b</gtr:id><gtr:otherNames>McCarthy MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>644AEB57519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8287B5E9-5368-4F36-B081-04A9CA6E7DAB</gtr:id><gtr:title>Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc68d5cb206cac70047dbc415d056fd1"><gtr:id>fc68d5cb206cac70047dbc415d056fd1</gtr:id><gtr:otherNames>Wheeler E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5aa6fa745cb4a7.94596470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEC0479D-EE65-4F60-84AA-919C61885E85</gtr:id><gtr:title>Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0816bc5cd021e6eb031d375705eaa3ba"><gtr:id>0816bc5cd021e6eb031d375705eaa3ba</gtr:id><gtr:otherNames>GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>CaQDUQwXNMb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6C38F99-9BBC-4755-B710-B5788270F83B</gtr:id><gtr:title>Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6874f0730e0ee9d916500cbf61ff1dc2"><gtr:id>6874f0730e0ee9d916500cbf61ff1dc2</gtr:id><gtr:otherNames>Usher CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58c00e8f5f76c2.42444508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDF17DFA-4420-4E06-95CA-F0A0A7F47B8E</gtr:id><gtr:title>Genome-wide associations for birth weight and correlations with adult disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95ce9b9b8fd10225d3aa14853e1462a1"><gtr:id>95ce9b9b8fd10225d3aa14853e1462a1</gtr:id><gtr:otherNames>Horikoshi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58c00e8d379250.66357831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15382CF1-89A7-4F12-80B6-379A5FA97E4B</gtr:id><gtr:title>Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3910f4e5f22b59f0f4314fa19d594e18"><gtr:id>3910f4e5f22b59f0f4314fa19d594e18</gtr:id><gtr:otherNames>InterAct Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_13659_29_21717116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E1B2DBC-485A-409F-9D28-4BC04216D8DB</gtr:id><gtr:title>Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c89be373aae853cd567a545d75230ff"><gtr:id>8c89be373aae853cd567a545d75230ff</gtr:id><gtr:otherNames>Yaghootkar H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>5675dec5d446c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>540334F3-1CA9-43B6-9FA5-F6FDDF4E81B4</gtr:id><gtr:title>FTO genotype is associated with phenotypic variability of body mass index.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c4df4241d0e1193d5aeffe9e19aab3d"><gtr:id>1c4df4241d0e1193d5aeffe9e19aab3d</gtr:id><gtr:otherNames>Yang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_13659_29_22982992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FC44764-19D0-4135-84D2-B4D6418F7E38</gtr:id><gtr:title>Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5912458748451415a9d05f110838af7d"><gtr:id>5912458748451415a9d05f110838af7d</gtr:id><gtr:otherNames>Ma RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>aoWYCM8Nz6Z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C60C6E93-0B7C-4DC1-9944-661E2A5EDA17</gtr:id><gtr:title>Gene-obesogenic environment interactions in the UK Biobank study.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07f821046a15bbd1b7e1e58e84710919"><gtr:id>07f821046a15bbd1b7e1e58e84710919</gtr:id><gtr:otherNames>Tyrrell J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>58c00e8cb21d01.93112184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>627500ED-A82E-42C3-A8BA-633D4B309929</gtr:id><gtr:title>Exome-wide association study of plasma lipids in &amp;gt;300,000 individuals.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5bd460d7c4191ca576be5ee64e1baf7"><gtr:id>e5bd460d7c4191ca576be5ee64e1baf7</gtr:id><gtr:otherNames>Liu DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aa6fa75ed0671.90603310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>170C3545-15D7-49AA-A1CC-D1761574295E</gtr:id><gtr:title>Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4b7bc19305dd6af580828a208894462"><gtr:id>b4b7bc19305dd6af580828a208894462</gtr:id><gtr:otherNames>De Silva NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>pm_13659_29_21282362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37923465-6606-4169-88E1-2C8B6E0AB824</gtr:id><gtr:title>Analysis with the exome array identifies multiple new independent variants in lipid loci.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69dea32a060ad338472db49f9e53b2d8"><gtr:id>69dea32a060ad338472db49f9e53b2d8</gtr:id><gtr:otherNames>Kanoni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58c55669c17705.02240323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1322C54-C54B-4037-87BF-FAB1AEA9DBF4</gtr:id><gtr:title>Common variants near MC4R are associated with fat mass, weight and risk of obesity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f85b98982852df462ea3285f6431bafd"><gtr:id>f85b98982852df462ea3285f6431bafd</gtr:id><gtr:otherNames>Loos RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>628E44F7AE9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76D95E09-E0F9-4D3C-955D-F5182547A0BF</gtr:id><gtr:title>Genome-Wide Association Analyses in 128,266 Individuals Identifies New Morningness and Sleep Duration Loci.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a4f55f33c7285d7400d331324f229b8"><gtr:id>4a4f55f33c7285d7400d331324f229b8</gtr:id><gtr:otherNames>Jones SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>58c00e8d9b9300.21146838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA2B3CCF-8AD5-406C-B6F0-A23782843407</gtr:id><gtr:title>Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c89be373aae853cd567a545d75230ff"><gtr:id>8c89be373aae853cd567a545d75230ff</gtr:id><gtr:otherNames>Yaghootkar H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>58c00e8de044c8.45364157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EB41D60-1542-4276-867A-36D2CC05160F</gtr:id><gtr:title>Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07f821046a15bbd1b7e1e58e84710919"><gtr:id>07f821046a15bbd1b7e1e58e84710919</gtr:id><gtr:otherNames>Tyrrell J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>58c00e8e566402.37590428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CB46A44-A5A7-46F5-9C23-D164ABF171AE</gtr:id><gtr:title>Genetic association analysis of LARS2 with type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f626bbcb11eff0152579112fdf5aa1f6"><gtr:id>f626bbcb11eff0152579112fdf5aa1f6</gtr:id><gtr:otherNames>Reiling E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>CE3EF71758F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCE376EE-886D-4CFD-B4F7-548279983CBF</gtr:id><gtr:title>Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/575fc3f8e9fb59364256f12a5bea1c28"><gtr:id>575fc3f8e9fb59364256f12a5bea1c28</gtr:id><gtr:otherNames>Jafar-Mohammadi B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>87487F90A6C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0860816B-6CA5-440E-909A-2AF4FB62B1A6</gtr:id><gtr:title>Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment.</gtr:title><gtr:parentPublicationTitle>Pharmacogenetics and genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c56a4604761c5360383524ffc595c8e4"><gtr:id>c56a4604761c5360383524ffc595c8e4</gtr:id><gtr:otherNames>Donnelly LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1744-6872</gtr:issn><gtr:outcomeId>doi_55faa1aa1ba39b64</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601261</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>